Highside Capital Management
Overview
Highside Capital Management is a hedge fund sponsor that employs long/short equity strategy to make its investments in the public equity markets of the United States .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| InterVenn Biosciences | Aug 2021 | Series C | Co-investor |
| Mythic Therapeutics | Dec 2021 | Series B | Co-investor |
| Strata Oncology | Jul 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Highside Capital Management based?
Highside Capital Management is headquartered in Dallas, Texas, United States.
When was Highside Capital Management founded?
Highside Capital Management was founded in 2003.
How many portfolio companies does Highside Capital Management have?
Highside Capital Management has 3 portfolio companies in Caplight's dataset.
What are some companies in Highside Capital Management's portfolio?
Portfolio companies visible on Caplight include InterVenn Biosciences, Mythic Therapeutics, Strata Oncology.
What was Highside Capital Management's most recent investment shown here?
Highside Capital Management's most recent investment in this portfolio sample was in Mythic Therapeutics in 2021.
What sectors does Highside Capital Management focus on?
Highside Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Highside Capital Management focus on?
Highside Capital Management typically invests at the Mid stage.
What is Highside Capital Management's AUM?
Highside Capital Management's assets under management are estimated between $1.0B and $10.0B.